Skip to content

Immix Biopharma, Inc. IMMX Accrued Professional Services

Accrued Professional Services at other companies

Acacia Research logo
Acacia ResearchACTG
$1.71M+91.5%
Photronics logo
PhotronicsPLAB
$2.23M+53.7%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$787K
MidCap Financial Investment Corporation logo
MidCap Financial Investment CorporationMFIC
$409K
Blue Bird Corporation logo
Blue Bird CorporationBLBD
$53.75M+26.6%
TransUnion logo
TransUnionTRU
$461.5M-6.3%

Other financials

Income statement

See full
Operating income-$10.8M-131%
Net income-$10.1M-122%
EPS (diluted)-$0.18-20.0%

Balance sheet

See full
Cash & equivalents$79.3M+398%
Total debt$1.0M-2.0%
Total equity$84.4M+779%
Total assets$95.8M+382%

Cash flow

See full
Operating cash flow-$9.8M-483%
CapEx$32.5K-52.0%
Free cash flow-$9.9M-462%

Valuation

See full
Market cap$691.97M+1,008%
Enterprise value$613.75M+1,190%

Returns & leverage

See full
Return on equity-74.4%-18.6pp
Debt / equity-0.1×
Current ratio8.8×+7.0×

Where this comes from

Reported directly by Immix Biopharma, Inc. in its filing.

Tagged under the XBRL concept IMMX:AccruedProfessionalServices.

The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immix Biopharma, Inc.'s accrued professional services.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Immix Biopharma, Inc.'s accrued professional services?
Immix Biopharma, Inc. (IMMX) reported accrued professional services of $206.93K in Q1 2026.
How has Immix Biopharma, Inc.'s accrued professional services changed year-over-year?
Immix Biopharma, Inc.'s accrued professional services increased by 106.3% year-over-year, from $100.3K to $206.93K.
What does accrued professional services mean?
This captures the outstanding financial obligations for legal, consulting, accounting, or other professional services rendered to the company. It is a measure of short-term liabilities arising from essential business support functions that have not yet been settled in cash.